InCarda Therapeutics
PrivateLast Round
Series D
Jun 15, 2022
Total Funding Raised
$77.56M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
InCarda Therapeutics is a biopharmaceutical company that develops innovative inhaled therapies for the targeted treatment of cardiovascular conditions, including paroxysmal atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InCarda Therapeutics Comparables
Compare InCarda Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HUYA Bioscience International | 78% | |
| Acesion Pharma | 77% | |
| Philip Morris International | 73% | |
InCarda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 15, 2022 | ||||
| Series C | Oct 21, 2020 | ||||
| Series B | Nov 8, 2018 | ||||
| Series A | Apr 28, 2015 | ||||
| Private Placement | Dec 5, 2014 | ||||
Debt | Aug 28, 2013 |
Key People
Founding team and executive leadership
InCarda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series B, Series C |
| Morningside Ventures | Series B, Series C, Series A |
| Innoviva | Series D, Series C |
| Asset Management Ventures | Series B |
| HealthCap | Series C, Series B |
| Morningside Group | Series B, Series C, Series A |
| Sofinnova Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 39% MoM.
- Apr 17, 2026
Monthly visitors increased 54% MoM.
InCarda Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InCarda Therapeutics's valuation, stock price, and market status.